TELA Bio, Inc.
TELA
$1.95
$0.010.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.26M | -9.21M | -10.37M | -12.60M | -5.66M |
| Total Depreciation and Amortization | 267.00K | 266.00K | 263.00K | 249.00K | 234.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.85M | 2.47M | 1.86M | 1.56M | -5.79M |
| Change in Net Operating Assets | -579.00K | -1.05M | -737.00K | 90.00K | -3.17M |
| Cash from Operations | -9.73M | -7.53M | -8.98M | -10.70M | -14.38M |
| Capital Expenditure | -32.00K | -264.00K | -122.00K | -299.00K | -304.00K |
| Sale of Property, Plant, and Equipment | -- | 5.44M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 170.00K | -5.37M | 0.00 | 366.00K | 5.00M |
| Cash from Investing | 138.00K | -190.00K | -122.00K | 67.00K | 4.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.00K | 42.92M | 117.00K | 6.00K | 384.00K |
| Repurchase of Common Stock | -177.00K | -11.00K | -19.00K | -11.00K | -328.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -116.00K | 42.91M | 98.00K | -5.00K | 56.00K |
| Foreign Exchange rate Adjustments | -134.00K | 182.00K | -188.00K | -12.00K | 46.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.84M | 35.37M | -9.20M | -10.65M | -9.59M |